n Competitors

McKesson Corporation, currently ranked 5th on the FORTUNE 500, is a healthcare services and information technology company dedicated to making the business of healthcare run better. For businesses across healthcare, being healthy means having what you need to operate more efficiently and improve the lives of patients. McKesson champions those working on the front lines of healthcare by helping them deliver better care at lower costs. We see the industry the way no one else can: comprehensively. And we’re confident in the impact we create because of that view. To learn more about how we help customers, read our blog http://www.mckesson.com/blog/

Cardinal Health is a distributor of pharmaceuticals and specialty products; a supplier of home-health and direct-to-patient products and services; an operator of nuclear pharmacies and manufacturing facilities; a provider of performance and data solutions; and a global manufacturer and distributor of medical and laboratory products. Our company’s customer-centric focus drives continuous improvement and leads to innovative solutions that improve people’s lives every day. Disclaimer: LinkedIn is a third-party site unaffiliated with Cardinal Health. Cardinal Health is not responsible for the privacy or security policies or practices on LinkedIn or on any of the third-party websites that we may link to through LinkedIn. You should carefully review the privacy and security practices of LinkedIn and linked third-party websites. We do not necessarily endorse any information found here nor are we responsible for the accuracy of any information, opinions, claims, or advice found here or shared here by our followers. By posting content, ideas, or pictures, you grant Cardinal Health a non-exclusive, royalty-free, perpetual, and worldwide license to use your content and any images posted by you, including the rights to copy, distribute, transmit, display, reproduce, edit, translate, and reformat, and incorporate into a collective work. Cardinal Health reserves all rights relating to the company's LinkedIn account, including removing postings and prohibiting individuals from participating on the page.

Quest Diagnostics (NYSE: DGX) empowers people to take action to improve health outcomes. Derived from the world's largest database of clinical lab results, our diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve health care management. Quest annually serves one in three adult Americans and half the physicians and hospitals in the United States, and our 47,000 employees understand that, in the right hands and with the right context, our diagnostic insights can inspire actions that transform lives. The company offers physicians the broadest test menu (3,000+ tests), is a pioneer in developing innovative new tests, is the leader in cancer diagnostics, provides anatomic pathology (AP) services, & interpretive consultation through its medical & scientific staff of about 900 M.D.s & Ph.D.s. The company reported 2020 revenues of $9.44 billion. Quest Diagnostics offers the most extensive clinical testing network in the U.S., with laboratories in most major metropolitan areas, & in Mexico, the UK & India. The company also operates four esoteric laboratories, 40 outpatient AP laboratories, & 160 smaller, rapid-response laboratories. Patients may have specimens collected in any of the company’s approximately 2,250 patient service centers. On a typical workday, testing is performed for about 550,000 patients. Quest Diagnostics empowers healthcare organizations & clinicians with state-of-the-art connectivity solutions. The company is the leading provider of pre-employment drugs-of-abuse screening for employers & risk assessment services for the life insurance industry. It is the world’s 2nd largest provider of clinical trials testing for new pharmaceuticals. More information is available at www.questdiagnostics.com. Language Assistance / Non-Discrimination Notice Asistencia de Idiomas / Aviso de no Discriminación 語言協助 / 不歧視通知 www.QuestDiagnostics.com/home/nondiscrimination